Answers are grounded in this paper and cite their sources.
Rationale: Fructose-1,6-bisphosphatase deficiency is an autosomal recessive disorder with an extremely high mortality rate, if left undiagnosed and untreated. Patient concerns: Case 1 was a 2-year-old girl who was admitted to the pediatric intensive care unit because of fever lasting for 1 day and shortness of breath lasting for 5 hours with a history of hunger prior to onset. Her medical history was unremarkable. Case 2 was a newborn child who was the brother of case 1 and had the same presentation. Diagnoses: Complete exon gene sequencing of the 2 patients revealed 2 mutation sites on the FBP1 gene, which were heterozygous variants c.778(exon6)G>A and c.977(exon7)T>C. The c.778(exon6)G>A variant was inherited from her father. The c.977(exon7)T>C variant was inherited from the mother and is a new mutation that has not yet been reported. The resulting fructose-1,6-bisphosphatase deficiency is an autosomal recessive inherited disease. Interventions: We provided treatment, such as respiratory support, correction of acidosis, and stabilization of the internal environment. Outcomes: The treatment results were remarkable, with no complications at the 3-month follow-up. Lessons: The 2 patients reported here are close siblings, and the maternal mutation c.977(exon7)T>C noted in these patients has not been reported before. In clinical practice, the possibility of fructose-1,6-bisphosphatase deficiency should be considered for acute infection onset, severe metabolic acidosis, and hypoglycemia. Early gene sequencing can confirm the disease, and timely, proper treatment and long-term dietary control can prevent death, promote growth and development, and improve the quality of life of the affected children.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: